Cargando…

Bringing function to the forefront of cell therapy: how do we demonstrate potency?

Unlike conventional pharmaceuticals, biologics and Advanced Therapy Medicinal Products (ATMPs) are required to meet a standard of “potency” as part of the final release criteria at completion of manufacture. During early phase clinical trials, most regulatory agencies have been willing to accept ver...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowdell, Mark W., Weil, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366357/
https://www.ncbi.nlm.nih.gov/pubmed/37497223
http://dx.doi.org/10.3389/fimmu.2023.1226841

Ejemplares similares